Stockscreener 앱 받기
281.46
0.74%
2.06
시간 외 거래:
281.46
전일 마감가:
$279.40
열려 있는:
$280.27
하루 거래량:
830.74K
Relative Volume:
1.27
시가총액:
$23.08B
수익:
$14.14B
순이익/손실:
$942.70M
주가수익비율:
24.94
EPS:
11.2856
순현금흐름:
$1.38B
1주 성능:
+3.48%
1개월 성능:
+10.62%
6개월 성능:
+4.26%
1년 성능:
+11.66%
1일 변동 폭
$277.61
$282.10
1주일 범위
$268.44
$290.65
52주 변동 폭
$244.52
$293.72
래버러토리 코퍼레이션 Stock (LH) Company Profile
명칭
Labcorp Holdings Inc
전화
(336) 229-1127
주소
358 S MAIN ST, BURLINGTON, NC
Compare LH vs TMO, DHR, IDXX, NTRA, A
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
LH
Labcorp Holdings Inc
|
281.46 | 22.91B | 14.14B | 942.70M | 1.38B | 11.29 |
TMO
Thermo Fisher Scientific Inc
|
526.46 | 194.53B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
179.14 | 125.84B | 24.78B | 3.68B | 5.29B | 5.1743 |
IDXX
Idexx Laboratories Inc
|
545.00 | 43.58B | 4.45B | 1.10B | 1.06B | 13.59 |
NTRA
Natera Inc
|
264.22 | 38.26B | 2.50B | -226.32M | 71.51M | -1.6412 |
A
Agilent Technologies Inc
|
133.46 | 37.52B | 7.23B | 1.41B | 1.09B | 4.979 |
래버러토리 코퍼레이션 Stock (LH) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-07-10 | 다운그레이드 | HSBC Securities | Buy → Hold |
| 2025-04-02 | 개시 | Redburn Atlantic | Buy |
| 2025-03-04 | 업그레이드 | Citigroup | Neutral → Buy |
| 2025-01-07 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2024-12-10 | 재개 | Jefferies | Buy |
| 2024-10-30 | 업그레이드 | HSBC Securities | Hold → Buy |
| 2024-10-01 | 개시 | Piper Sandler | Neutral |
| 2024-03-25 | 업그레이드 | Argus | Hold → Buy |
| 2024-02-26 | 개시 | Leerink Partners | Outperform |
| 2024-02-09 | 개시 | Evercore ISI | In-line |
| 2024-01-03 | 개시 | Barclays | Equal Weight |
| 2023-09-06 | 개시 | HSBC Securities | Hold |
| 2022-12-12 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2022-09-19 | 다운그레이드 | Argus | Buy → Hold |
| 2022-08-22 | 재개 | Morgan Stanley | Overweight |
| 2022-01-28 | 다운그레이드 | Deutsche Bank | Buy → Hold |
| 2021-01-11 | 업그레이드 | Argus | Hold → Buy |
| 2021-01-11 | 다운그레이드 | Wolfe Research | Peer Perform → Underperform |
| 2021-01-08 | 다운그레이드 | Wolfe Research | Outperform → Peer Perform |
| 2020-07-14 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2020-07-13 | 업그레이드 | Wolfe Research | Peer Perform → Outperform |
| 2020-06-02 | 재개 | Deutsche Bank | Buy |
| 2020-05-15 | 업그레이드 | Mizuho | Neutral → Buy |
| 2020-04-29 | 다운그레이드 | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2020-04-27 | 업그레이드 | Citigroup | Neutral → Buy |
| 2020-04-27 | 업그레이드 | Wolfe Research | Underperform → Peer Perform |
| 2020-01-08 | 개시 | Wells Fargo | Overweight |
| 2019-07-16 | 업그레이드 | BofA/Merrill | Underperform → Neutral |
| 2019-06-21 | 업그레이드 | Deutsche Bank | Hold → Buy |
| 2019-04-02 | 업그레이드 | Jefferies | Hold → Buy |
| 2019-01-17 | 개시 | UBS | Buy |
| 2019-01-03 | 다운그레이드 | BofA/Merrill | Neutral → Underperform |
| 2018-12-03 | 다운그레이드 | Craig Hallum | Buy → Hold |
| 2018-10-30 | 다운그레이드 | Argus | Buy → Hold |
| 2018-10-25 | 다운그레이드 | Canaccord Genuity | Buy → Hold |
| 2018-10-19 | 재개 | BofA/Merrill | Buy |
| 2018-06-07 | 업그레이드 | KeyBanc Capital Mkts | Sector Weight → Overweight |
| 2018-05-01 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2018-03-23 | 개시 | Argus | Buy |
모두보기
래버러토리 코퍼레이션 주식(LH)의 최신 뉴스
Labcorp Holdings Inc. (LH) Q3 2024 Earnings ReportResults, Call & Slides - TipRanks
Labcorp Prepares to Report Q2 Earnings: What's in the Cards? - TradingView
Global Cancer Biomarkers Market to Reach $37.8 Billion by 2035 as Precision Oncology Adoption Accelerates - GlobeNewswire Inc.
Will Labcorp (LH) Beat Estimates Again in Its Next Earnings Report? - Yahoo Finance
Labcorp Holdings Inc. (LH): Investor Outlook With A 10% Upside Potential - DirectorsTalk Interviews
Labcorp Holdings (LH) Q1 2026 Earnings Call Transcript - Fortune
Labcorp Holdings Inc. (N6B) Q1 2024 Earnings ReportResults, Call & Slides - TipRanks
Labcorp Holdings Inc. (N6B) Q4 2024 Earnings ReportResults, Call & Slides - TipRanks
Labcorp Holdings Inc. (N6B) Q3 2024 Earnings ReportResults, Call & Slides - TipRanks
Labcorp Holdings Inc (LH) Stock Up 3.7% but GF Value Says Overva - GuruFocus
Labcorp Holdings Inc. stock outperforms competitors on strong trading day - MarketWatch
Labcorp To Pay $14.5M To Settle Medicare Fraud Allegations Over Unnecessary Drug Testing - Yahoo Finance
Diagnostics Co. Labcorp Settles FCA Claims For $14.5M - Law360
Labcorp seen as a steady growth buy with cost c... - Pluang
Laboratory Corporation of America (LH) Settles for $14.5M Over F - GuruFocus
Labcorp Holdings: The Story Has Not Changed Materially - Seeking Alpha
Labcorp to Pay $14.5 Million to Settle False Claims Act Allegations - marketscreener.com
Labcorp Holdings Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Cell-Based Assay Services for Preclinical Use Only Global Market Report 2026 Released — Profiles Charles River, Labcorp, Eurofins and Evotec - Yahoo Finance
Baird Adjusts Labcorp Price Target to $338 From $335, Maintains Outperform Rating - marketscreener.com
Labcorp declares quarterly dividend of $0.72 per share By Investing.com - Investing.com Nigeria
Labcorp stock holds steady as diagnostics demand stays central - Ad Hoc News
What are Wall Street analysts' target price for Labcorp Holdings stock? - MSN
Labcorp stock steadies on its diagnostics and drug development mix - Ad-hoc-news.de
Labcorp Holdings Inc. (LH) Declares Cash Dividend of $0.72 Per S - GuruFocus
Labcorp Declares $0.72 Quarterly Dividend Payable September 2026 - Minichart
Labcorp Declares $0.72 Quarterly Dividend Payable Sept. 11 - TradingView
Labcorp (NYSE: LH) sets $0.72 per-share dividend payable September 11, 2026 - Stock Titan
Labcorp stock holds steady as investors await its next catalyst - Ad-hoc-news.de
Labcorp Declares Quarterly Dividend - AOL.com
Labcorp declares quarterly dividend of $0.72 per share - Investing.com
Labcorp Keeps Quarterly Dividend at $0.72 a Share, Payable Sept. 11 to Holders of Record Aug. 28 - marketscreener.com
Labcorp sets 72-cent dividend for Sept. 11 payout - Stock Titan
Here's what to expect from Labcorp Holdings’ next earnings report - MSN
Labcorp stock holds its business focus. Clinical diagnostics remain the core. - ad-hoc-news.de
Labcorp Holdings (LH) Expands Cancer And Liver Testing, Is It Fully Priced? - Sahm
Evercore ISI Adjusts Price Target on Labcorp to $315 From $300 - Moomoo
Labcorp EVP Bryan Vaughn sells $66,968 in common stock By Investing.com - Investing.com South Africa
Labcorp chief legal officer Kyle sells $26,329 in common stock. - Investing.com UK
Labcorp EVP Bryan Vaughn sells $66,968 in common stock - Investing.com UK
Form 4 Labcorp Holdings Inc For: 6 July By Investing.com - Investing.com Nigeria
Labcorp chief legal officer Kyle sells $26,329 in common stock. By Investing.com - Investing.com Australia
Form 4 Labcorp Holdings Inc For: 6 July - Investing.com India
Labcorp (NYSE: LH) legal chief sells shares, exercises 256 stock units - Stock Titan
Labcorp (LH) EVP sells shares after RSU vesting under Rule 10b5-1 plan - Stock Titan
Enterprise value to revenue forward of Labcorp Holdings Inc. – NYSE:LH - TradingView
Labcorp Holdings Inc. (LH) Stock Analysis: Evaluating an 8.06% Potential Upside Amid Strong Buy Ratings - DirectorsTalk Interviews
Labcorp launches FDA-cleared blood test for Alzheimer's disease - MSN
래버러토리 코퍼레이션 (LH) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.45%
0.95%
자본화:
|
볼륨(24시간):